Serotonin antibodies in relation to immune activation in major depression

A RATING SCALE FOR DEPRESSION

1960 • 30,921 citations

Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies

1966 • 4,504 citations

Interleukin-6 and the acute phase response

1990 • 2,740 citations

The cytokine network

1989 • 785 citations

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

1995 • 614 citations

Indicators of immune activation in major depression

1996 • 387 citations

Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells.

1987 • 358 citations

Reduction of immune function in life stress and depression

1990 • 345 citations

Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine

1995 • 301 citations

Α Review on the Acute Phase Response in Major Depression

1993 • 227 citations

N-glycosylation of serum proteins in disease and its investigation using lectins

1992 • 223 citations

Crossed immuno-affinoelectrophoresis

1973 • 221 citations

Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls

1994 • 190 citations

Relationship between sleep and mood in patients with rapid-cycling bipolar disorder

1996 • 176 citations

First isolates of infectious human Borna disease virus from patients with mood disorders.

1996 • 165 citations

Higher α1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illness

1992 • 145 citations

Natural autoantibodies might prevent autoimmune disease

1986 • 136 citations

Elevated levels of acute phase plasma proteins in major depression

1992 • 133 citations

Disturbances in acute phase plasma proteins during melancholia: Additional evidence for the presence of an inflammatory process during that illness

1992 • 124 citations

Antiphospholipid, antinuclear, epstein-barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients

1991 • 108 citations

New trends in ganglioside research: Neurochemical and neuroregenerative aspects

1986 • 93 citations

Microheterogeneity forms of alpha1-acid glycoprotein as indicators of rheumatoid arthritis activity

1987 • 87 citations

Changes in glycosylation of acute-phase proteins in health and disease: Occurrence, regulation and function

1994 • 82 citations

Concentration and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depressive disorder

1996 • 52 citations

Repair of Mucosal Damage Induced by Ethanol in the Rat Stomach

1988 • 51 citations

Changes in the serum concentration and the glycosylation of human αl-acid glycoprotein and αl-protease inhibitor in severely burned persons: relation to interleukin-6 levels

1990 • 49 citations

Purification and properties of a human plasma endogenous modulator for the platelet tricyclic binding/serotonin transport complex

1987 • 48 citations

Cytokines and autoimmunity

1994 • 48 citations

Cytokines in health and disease

1993 • 36 citations

Antibodies Against Central Nervous System Tissue (Anti-Cns) Detected by Elisa and Western Blotting: Marker Antibodies for Neuropsychiatric Manifestations in Connective Tissue Diseases

1991 • 33 citations

Increased levels of alpha‐1‐acid glycoprotein and interleukin‐6 in refractory depression

1995 • 29 citations

Antibodies against serotonin and gangliosides in schizophrenia and major depressive disorder

1992 • 22 citations

Hormones, Brain, and Neuropsychopharmacology

1993 • 1 citations